Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

ORABASE HCA

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 15 USDMF, 11 CEP/COS, 2 JDMF, 5 EU WC, 4 KDMF, 19 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

151 FDF Dossiers, 55 FDA Orange Book, 58 Europe, 13 Canada, 13 Australia, 6 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;RECTAL - 10%, CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION/DROPS;OTIC - EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG BASE/ML;0.5MG/ML, AEROSOL, METERED;TOPICAL - 1%;1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 4 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 13 Nanjing Well Pharmaceutical, 10 Kirsch Pharma, 1 ACG Worldwide, 18 Actylis, 1 Aeon Procare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 42 BASF, 8 Beneo, 1 BioSpectra, 3 CD Formulation, 15 Corel Pharma Chem, 1 Doshion Polyscience, 3 Esteem Industries, 4 Finar, 13 Gangwal Chemicals, 3 Ideal Cures, 9 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 7 Lubrizol Life Science Health, 7 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 21 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Symrise, 2 The Dow Chemical Company, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

65 Topical, 51 Solubilizers, 45 Coating Systems & Additives, 38 Thickeners and Stabilizers, 33 Parenteral, 26 Fillers, Diluents & Binders, 25 Controlled & Modified Release, 25 Emulsifying Agents, 21 Film Formers & Plasticizers, 20 Taste Masking, 16 Surfactant & Foaming Agents, 16 Granulation, 14 Direct Compression, 10 Lubricants & Glidants, 9 Rheology Modifiers, 7 API Stability Enhancers, 5 Chewable & Orodispersible Aids, 5 Empty Capsules, 4 Co-Processed Excipients, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Disintegrants & Superdisintegrants, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 6 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 7 Regulatory FDF Prices

MARKET PLACE

20 APIs, 2 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
27/09/2025	Pfizer CentreOne	U.S.A	PHARMACIA & UPJOHN COMPANY LLC Kalamazoo US	CEP 2002-160 - Rev 05	Hydrocortisone acetate, Micronised	2024-12-11	Valid	Chemical		334
27/09/2025	Symbiotec Pharmalab	India	SYMBIOTEC PHARMALAB PRIVATE LIMITED Indore IN	CEP 2016-228 - Rev 03	Hydrocortisone acetate, Micronised, Grades I and II	2025-09-18	Valid	Chemical		334

ORABASE HCA

ORABASE HCA

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers

15 USDMF

11 CEP/COS

2 JDMF

5 EU WC

4 KDMF

19 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

151 FDF Dossiers

55 FDA Orange Book

58 Europe

13 Canada

13 Australia

6 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;RECTAL - 10%

CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION/DROPS;OTIC - EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG BASE/ML;0.5MG/ML

AEROSOL, METERED;TOPICAL - 1%;1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

4 SPI Pharma

10 DKSH

1 Pharm-RX Chemical

1 Boai NKY Pharmaceuticals Ltd

1 Gangwal Healthcare

13 Nanjing Well Pharmaceutical

10 Kirsch Pharma

1 ACG Worldwide

18 Actylis

1 Aeon Procare

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

42 BASF

8 Beneo

1 BioSpectra

3 CD Formulation

15 Corel Pharma Chem

1 Doshion Polyscience

3 Esteem Industries

4 Finar

13 Gangwal Chemicals

3 Ideal Cures

9 Kerry

3 Kima Chemical

6 Lonza Capsugel

7 Lubrizol Life Science Health

7 Microlex e.U

2 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Novo Excipients

1 Pharmatrans-Sanaq

3 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

16 Roquette

21 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Symrise

2 The Dow Chemical Company

2 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

65 Topical

51 Solubilizers

CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons